Cetrorelix Acetate 0.25 mg
(SC Lyophilized Injection)
The group of companies
Every formulation we develop is built around therapeutic effectiveness, manufacturing precision, and long-term quality, supporting pharmaceutical partners worldwide.

Cetrorelix Acetate 0.25 mg
(SC Lyophilized Injection)

Dydrogesterone 10 mg (Oral)

Estradiol hemihydrate 2 mg (Oral)

Menotropin 150 IU (IM/SC Injection)

Menotropin 1200 IU (IM/SC Injection)

Progestetone 100 mg/ mL
(IM Injection - Dispo pack)

Progestetone Soft Gelatin Capsules 200mg (Oral/ Vaginal/ Anal)

Progestetone Soft Gelatin Capsules 400mg (Oral/ Vaginal/ Anal)

Progestetone Gel 8% w/w (Vaginal)

Progestetone Sustained Release Tablets 200mg (Oral)

Hydroxyprogesterone Caproate 250 mg/mL (IM Injection Dispo Pack)

Hydroxyprogesterone Caproate 500 mg/ 2 mL (IM Injection Dispo Pack)
Our formulations are developed through a carefully controlled process that combines pharmaceutical research, formulation expertise, precision manufacturing, and rigorous quality systems. This integrated approach ensures every product reflects consistency, safety, and reliability.
Scientific expertise guiding the pharmacokinetics and bioavailability of every single formulation.
State-of-the-art production environments to prevent cross-contamination and guarantee active stability.
Strict QA protocols integrated deeply in the formulation lifecycle to ensure global compliance.
Specialized interest in fertility and maternal care, filling critical pharmaceutical gaps in women's health.
Our manufacturing practices and technical dossiers are fully aligned with global regulatory directives.
Active support to pharmaceutical partners through continuous document transfers and transparent support.